The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
In article number 1906644, Guoqing Pan and co‐workers comprehensively discuss the recent progress of molecularly imprinted synthetic antibodies (MISAs) from fundamental chemical design to their emerging biomedical applications. Meanwhile, the possibility of MISAs as qualified substitutes or even to transcend the performance of natural antibodies is discussed from the perspective of frontier needs...
Billions of dollars are invested into the monoclonal antibody market every year to meet the increasing demand in clinical diagnosis and therapy. However, natural antibodies still suffer from poor stability and high cost, as well as ethical issues in animal experiments. Thus, developing antibody substitutes or mimics is a long‐term goal for scientists. The molecular imprinting technique presents one...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.